Biotelemetry Inc. buy tamam
Start price
05.05.17
/
50%
€25.30
Target price
26.04.18
€35.18
Performance (%)
35.58%
End price
26.04.18
€34.30
Summary
This prediction ended on 26.04.18 with a price of €34.30. With a performance of 35.58% the BUY prediction by tamam was a big success. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biotelemetry Inc. | - | - | - | - |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by tamam for this prediction
In the thread Biotelemetry Inc. diskutieren
BioTelemetry: It's a buying opportunity as
the LifeWatch deal is still very much intact, and investors should consider a particularly tough comp BEAT had this quarter.
https://seekingalpha.com/article/4130067-biotelemetry-key-partnership-apples-heart-study-featuring-apples-watch
(Vom Mitglied beendet)


